U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.185T>C (p.Val62Ala) AND Monogenic diabetes

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 25, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003480800.2

Allele description [Variation Report for NM_000162.5(GCK):c.185T>C (p.Val62Ala)]

NM_000162.5(GCK):c.185T>C (p.Val62Ala)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.185T>C (p.Val62Ala)
Other names:
NM_000162.5(GCK):c.185T>C; p.Val62Ala
HGVS:
  • NC_000007.14:g.44153324A>G
  • NG_008847.2:g.49847T>C
  • NM_000162.5:c.185T>CMANE SELECT
  • NM_001354800.1:c.185T>C
  • NM_033507.3:c.188T>C
  • NM_033508.3:c.182T>C
  • NP_000153.1:p.Val62Ala
  • NP_001341729.1:p.Val62Ala
  • NP_277042.1:p.Val63Ala
  • NP_277043.1:p.Val61Ala
  • LRG_1074t1:c.185T>C
  • LRG_1074t2:c.188T>C
  • LRG_1074:g.49847T>C
  • LRG_1074p1:p.Val62Ala
  • LRG_1074p2:p.Val63Ala
  • NC_000007.13:g.44192923A>G
  • NM_000162.3:c.185T>C
Protein change:
V61A
Links:
dbSNP: rs1444739794
NCBI 1000 Genomes Browser:
rs1444739794
Molecular consequence:
  • NM_000162.5:c.185T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.185T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.188T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.182T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Monogenic diabetes
Identifiers:
MONDO: MONDO:0015967; MedGen: C3888631

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004223875ClinGen Monogenic Diabetes Variant Curation Expert Panel
reviewed by expert panel

(ClinGen Monogenic Diabetes ACMG Specifications GCK V1.3.0)
Pathogenic
(Jul 25, 2024)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Monogenic Diabetes Variant Curation Expert Panel, SCV004223875.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.185T>C variant in the glucokinase gene, GCK, causes an amino acid change of valine to alanine at codon 62 (p.(Val62Ala)) of NM_000162.5. GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2). This variant is also predicted to be deleterious by computational evidence, with a REVEL score of 0.97, which is greater than the MDEP VCEP threshold of 0.70 (PP3). MDEP wild type quality control measures were met, and the relative activity Index (RAI) of this variant was found to be 0.23, which is below the MDEP cutoff (<0.5) (PS3_Moderate; PMID: 16731834). This variant has an incomputable Popmax filtering allele frequency in gnomAD v2.1.1 due to 0 copies in the European non-Finnish subpopulation and 1 copy in the African subpopulation, below the ClinGen MDEP threshold for PM2_Supporting (Popmax FAF ≤0.000003 and ≤ 2 copies in ENF and ≤1 copy in any other subpopulation) (PM2_Supporting). It was identified in at least two unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID: 18399931, PMID: 9736233, ClinVar ID: 585917). One of these individuals has a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6% and negative antibodies) (PP4_Moderate; PMID: 18399931). This variant segregated with diabetes, with five informative meioses in one family with MODY (PP1_Strong; PMID: 9736233, internal lab contributors). Another missense variant, c.184G>A (p.Val62Met) has been interpreted as pathogenic by the ClinGen MDEP and p.Val62Ala has a greater Grantham distance (PM5). In summary, the c.185T>C variant meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP VCEP (specification version 1.3.0, approved 8/11/2023): PP4_Moderate, PP1_Strong, PM5, PS3_Moderate, PP2, PP3, PM2_Supporting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024